Authors' Reply: SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?

Schrezenmeier, Eva; Sattler, Arne; Halleck, Fabian; Budde, Klemens

Schrezenmeier, Eva; Sattler, Arne; Halleck, Fabian; Budde, Klemens.

Schrezenmeier E; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany eva-vanessa.schrezenmeier@charite.de.
Sattler A; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Halleck F; Department for General and Visceral Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Budde K; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.

J Am Soc Nephrol ; 33(4): 870-871, 2022 04.

Article in English | MEDLINE | ID: covidwho-1686211

Subject(s)

COVID-19; Kidney Transplantation; COVID-19/prevention & control; COVID-19 Vaccines; Humans; SARS-CoV-2; Transplant Recipients; Vaccination

Keywords

COVID-19; transplantation; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Am Soc Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: Asn.2022010033

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google